Skip to main content
Sarepta Therapeutics, Inc. logo

Sarepta Therapeutics, Inc. — Investor Relations & Filings

Ticker · SRPT ISIN · US8036071004 LEI · 549300IKDPIED8J8IG21 US Manufacturing
Filings indexed 1,061 across all filing types
Latest filing 2024-11-06 Interim / Quarterly Rep…
Country US United States of America
Listing US SRPT

About Sarepta Therapeutics, Inc.

https://www.sarepta.com/

Sarepta Therapeutics is a commercial-stage biopharmaceutical company that engineers precision genetic medicines for rare diseases. The company's research and development efforts are centered on RNA-targeted therapeutics and gene therapies, with a primary focus on treating rare neuromuscular and central nervous system disorders. Sarepta aims to accelerate the drug development process from discovery to patient application and is building significant gene therapy manufacturing capabilities to support its mission.

Recent filings

Filing Released Lang Actions
10-Q
Interim / Quarterly Report Q3 2024
2024-11-06 English
4
Director's Dealing
2024-09-17 English
3
Director's Dealing
2024-09-17 English
8-K
Board/Management Information Classification · 95% confidence The document is a Form 8-K filed with the SEC, which is a current report used to announce significant corporate events. The content includes the appointment of a new director, changes to the board size via amendment to bylaws, and related compensation details. These are announcements related to changes in the company's board of directors and governance structure. There are no financial statements or detailed financial data present, so it is not an Annual Report, Interim Report, or Earnings Release. The primary focus is on board and management changes, which fits the Board/Management Information category (MANG). The document length is 4535 characters, which is sufficient to contain substantive information rather than a brief announcement or certification. Therefore, the correct classification is MANG with high confidence.
2024-09-16 English
4
Director's Dealing
2024-09-06 English
4
Director's Dealing
2024-09-04 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.